医学信息Issue(17)：64-65,2.
复方苦参注射液联合同步放化疗治疗局部晚期非小细胞肺癌的临床观察
The Observation on Clinical Efficacy and Side Effects of Compound Kus Injection Given by Aerosol Inhalation and Intravenously in Treating Patients with Phase III Non-small Cell Lung Cancer
蒋忠君 1费新雄 1黄绪群 1王钢胜1
作者信息
- 1. 湖北省黄石市肿瘤医院肿瘤内1科，湖北 黄石 435000
- 折叠
摘要
Abstract
Objective To observe the recent clinical ef icacy and side ef ects of compound kushen injection given by aerosol inhalation and intravenously in treating patients with phase III Non-smal cel lung cancer. Methods 96 patients with phase III Non-smal cel lung cancer were randomly divided into two groups: the kushen group (n=48) and the control group (n=48). Both groups were treated with concurrent chemoradiotherapy, and the kushen group was given compound kushen injection plus aerosol inhalation in addition. Results The complete response rates in the kushen group and the control group are 16.7%、12.5% respectively, and the ef ective rates are 70.8%、64.6%, and both of them has no significant dif erences (P>0.05). The side ef ects such as myelosuppression, gastrointestinal reactions, radiation esophagitis in the kushen group were significantly lower than those in the control group, and the quality of life in the kushen group were bet er than that in the control group (P<0.05) Conclusion The compound kushen injection could not improve the clinical ef icacy, but it could al eviate the side ef ects caused by concurrent chemoradiotherapy so as to improve the quality of life.关键词
非小细胞肺癌/同步放化疗/复方苦参注射液Key words
Non-smal cell lung cancer/Concurrent chemoradiotherapy/Compound kushen injection引用本文复制引用
蒋忠君,费新雄,黄绪群,王钢胜..复方苦参注射液联合同步放化疗治疗局部晚期非小细胞肺癌的临床观察[J].医学信息,2013,(17):64-65,2.
